top of page
The Ella Dawson Foundation joins Cancer52
The Ella Dawson Foundation is the newest member of Cancer52! The Ella Dawson Foundation provides psychological, emotional, physical,...
Cancer52's newest member - The Young Tongues
Cancer52 are delighted to welcome The Young Tongues as the latest member to join Cancer52. The Young Tongues provide peer-to-peer support...
Cancer52 analysis on rare and less common cancer research spend
Cancer52 and the National Cancer Research Institute (NCRI) joined forces to create a report titled: Research into rare and less common...
Annual Review 2020-21
Cancer52 is delighted to present its Annual Review 2020-21. This report particularly highlights the strength and impact of Cancer52’s...
2021 All Stakeholder Briefing
On Wednesday 13th October, we hosted our Annual All Stakeholder Briefing, focusing on Early diagnosis for rare and less common cancers:...
Cancer52 Patient Survey Results - July 2020
We are pleased to share the results of the survey into the impact of Covid-19 on people with rare and less common cancers. The report is...
Cancer Patients Talk About Their Care
Cancer care was disrupted during the initial days of the Covid-19 pandemic but now services are up and running. But cancer patients are...
22 January 2020 All Member Meeting
The first quarterly All Member Meeting of 2020 is taking place on Wednesday 22nd January 2020, from 10am to 1pm in the Allen Room at St...
13 November 2019 Cancer52/NHS England & Improvement Workshop Rapid Diagnostic Centres & Pers
Rapid Diagnostic Centres (RDCs) and the roll out of personalised care are cornerstones of the implementation plans for Cancer Alliances...
16 October 2019 All Stakeholder Briefing
The annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical...
bottom of page